Table of Contents Table of Contents
Previous Page  768 / 1082 Next Page
Information
Show Menu
Previous Page 768 / 1082 Next Page
Page Background

S752

ESTRO 36 2017

_______________________________________________________________________________________________

related hypertension, 0.60 (0.38-0.95) for preeclampsia,

and 0.62 (0.46-0.85) for gestational diabetes.

Conclusion

For female cancer patients received radiotherapy, the risk

of severe postpartum hemorrhage might be increased.

EP-1423 the evaluation of sleep quality in cancer

patients following the diagnosis of a metastatic site

E. Yirmibesoglu Erkal

1

, D. Celik

1

, S. Ozmen

1

, G. Aksu

1

,

H.S. Erkal

2

1

Kocaeli University, Department of Radiation Oncology,

Kocaeli, Turkey

2

Sakarya University, Department of Radiation Oncology,

Sakarya, Turkey

Purpose or Objective

The aim of this study was the evaluate the sleep quality in

cancer patients receiving palliative radiotherapy for the

first time following the diagnosis of a metastatic site and

to correlate the sleep quality with the depression status

and the level of hopelessness.

Material and Methods

Forty-eight metastatic cancer patients about to receive

palliative radiotherapy were evaluated using

questionnaires for Pittsburgh Sleep Quality Index (PSQI),

Beck Depression Inventory (BDI) and Beck Hopelessness

Scale (BHS). There were 12 females and 36 males, their

ages ranging from 27 to 77 years (median, 60 years). 39

patients were married and 14 patients had at least high

school education. Primary tumor site was listed as the

respiratory system in 14 patients and the genitourinary

system in 14. The time from the diagnosis of cancer to the

diagnosis of the metastatic site was less than 1 month in

17 patients, 1 to 6 months in 10 and over 6 months in 21.

Radiotherapy was delivered for bone metastases in 34

patients and brain metastases in 9.

Results

PSQI scores ranged from 0 to 17 (median, 10) and those

with scores over 8 were classified as poor sleepers. BDI

scores ranged from 0 to 36 (median, 15) and those with

scores over 10 were classified as having mild to severe

depression. BHS scores ranged from 0 to 16 (median, 4)

and those with scores less than 4 were classified as having

no hopelessness at all. Accordingly, there were 30 patients

who were poor sleepers, 29 who had mild to severe

depression and 25 who were hopeless. There was a strong,

positive correlation between PSQI scores and BDI scores

which was statistically significant (p=0.002). There was no

correlation between PSQI scores and BHS scores. There

was a statistically significant association between poor

sleep quality and single marital status (p=0.04).

Conclusion

Self-administered measurements such as PSQI, BDI and

BHS might be used as a simple means to collect data on

multiple facets of the sleep quality, the depression status

and the level of hopelessness. In this study, poor sleepers

were prevalent among metastatic cancer patients. Poor

sleep, associated with mild to severe depression, deserves

adequate medical attention in terms of supportive care

EP-1424 Fertility preserving high precision

radiotherapy in non-uterine pelvic malignancies in

female

P.S. Sridhar

1

, N. Madhusudhan

1

, K. Roopesh

1

, J. Vijay

kumar

1

, M. Praveen kumar

1

, A. Jerrin

1

, A. Pichandi

1

, B.

Ajai kumar

1

1

Health Care Global Enterprises Ltd, Cyberknife-

Radiation oncology, Bangalore, India

Purpose or Objective

Fertility is major issue in non-uterine pelvic malignancies

in reproductive age requiring radiation. Primary pathology

is most crucial. Malignancies which are potentially curable

will always have concern for quality of life and fertility

issues. High precision radiotherapy will be able to meet

both ends. In this retrospective study attempt had made

to reduce the dose to reproductive organs to preserve the

reproductive functions.

Material and Methods

5 cases of non-uterine malignancies of age between 9-30

years who were treated between 2009-2014 were

retrospectively analysed.2 were sacral tumors,1 STS of

pelvis,1 Ca rectum,1 RMS pelvis. All of them had one or

combination of surgery,chemotherapy.All of them were

required radiation, 4 of them were treated with Intensity

modulated radiotherapy and 1 with cyberknife.

Age

at

diagn

osis

Diagn

osis

Treatme

nt

Dose

to

prima

ry

Me

an

Dos

e to

ute

rus

Mean

Dose to

ovary

Reprod

uctive

functio

n

foll

ow

up

9

RMS

pelvi

s

Chemoth

erapy,

Bladder

preservin

g surgery

50Gy/

25Fr

IMRT

25G

y

9Gy/12

Gy

Menstru

ating

6

year

s 6

mon

ths

16

STS

sacru

m

surgery,

chemoth

erapy

66Gy/

33Fr

IMRT

28G

y

7.7Gy/

46Gy

Not

Menstru

ating

6

year

s 4

mon

ths

28

STS

sacru

m

Surgery 2

times

60Gy/

30Fr

IMRT

28G

y

7Gy/10

Gy

Deliver

ed baby

5

year

s 4

mon

ths

25

Ca

rectu

m

Chemoth

erapy,

surgery

IMRT

60Gy/

28Fr

28G

y

12Gy/9

Gy

Menstru

ating

3

year

s 8

mon

ths

26

STS

pelvi

s

Surgery,

Chemoth

erapy

30Gy/

5Fr

Cyber

knife

28G

y

3Gy/8

Gy

Menstru

ating

3

year

s 5

mon

ths

Results

Among 5 cases, all are alive, 4 pts (80%) have no disease 1

pt has recurred in postoperative area.4 (80%) patients are

having menstruation,1 had delivered healthy baby.1

patient having primary amenorrhoea is treated with

hormones.

Conclusion

High precision radiotherapy in non-uterine malignancies

will be able to deliver effective dose to the target, able

to achieve within tolerance dose to reproductive organs.

In highly selective subset of patients fertility preservation

can be attempted. However proper randomised trials in

this regard is warranted.

EP-1425 Permit to enter no-fly-zone: Risk-adapted

mediastinal SBRT for oligometastases safe and

effective

D. Holyoake

1

, R. Cooke

2

, K. Chu

2

, A. Buckle

2

, M. Hawkins

1

1

CRUK MRC Oxford Institute for Radiation Oncology,

Department of Oncology- University of Oxford, Oxford,

United Kingdom

2

Oxford University Hospitals NHS Foundation Trust,

Department of Clinical Oncology, Oxford, United

Kingdom

Purpose or Objective

Stereotactic Body Radiation Therapy (SBRT) to the central

chest & mediastinum must be undertaken with caution due

to the risks of severe toxicity that may be observed with

extreme hypofractionation schedules. A risk-adapted